Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancements

Javier E. Villanueva-Meyer*, Spyridon Bakas, Pallavi Tiwari, Janine M. Lupo, Evan Calabrese, Christos Davatzikos, Wenya Linda Bi*, Marwa Ismail, Hamed Akbari, Philipp Lohmann, Thomas C. Booth, Benedikt Wiestler, Hugo J.W.L. Aerts, Ghulam Rasool, Joerg C. Tonn, Martha Nowosielski, Rajan Jain, Rivka R. Colen, Sarthak Pati, Ujjwal BaidPhilipp Vollmuth, David Macdonald, Michael A. Vogelbaum, Susan M. Chang, Raymond Y. Huang, Norbert Galldiks, Response Assessment in Neuro Oncology (RANO) group

*Corresponding author for this work

Research output: Contribution to journal(Systematic) Review article peer-review

Abstract

The development, application, and benchmarking of artificial intelligence (AI) tools to improve diagnosis, prognostication, and therapy in neuro-oncology are increasing at a rapid pace. This Policy Review provides an overview and critical assessment of the work to date in this field, focusing on diagnostic AI models of key genomic markers, predictive AI models of response before and after therapy, and differentiation of true disease progression from treatment-related changes, which is a considerable challenge based on current clinical care in neuro-oncology. Furthermore, promising future directions, including the use of AI for automated response assessment in neuro-oncology, are discussed.
Original languageEnglish
Pages (from-to)e581-e588
Number of pages8
JournalThe Lancet Oncology
Volume25
Issue number11
DOIs
Publication statusPublished - 1 Nov 2024

Keywords

  • HIGH-GRADE GLIOMAS
  • MRI
  • GLIOBLASTOMA
  • FEATURES
  • RADIOMICS
  • MUTATIONS
  • CLASSIFICATION
  • SIGNATURE
  • SURVIVAL
  • NETWORK

Fingerprint

Dive into the research topics of 'Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancements'. Together they form a unique fingerprint.

Cite this